Skip to main content
Veterinary Medicines

Orafluke 10 % w/v Oral Suspension

Authorised
  • Rafoxanide
  • Fenbendazole

Product identification

Medicine name:
Orafluke 10 % w/v Oral Suspension
Active substance:
  • Rafoxanide
  • Fenbendazole
Target species:
  • Cattle
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Rafoxanide
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Fenbendazole
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        60
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC13
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • 2.5 L (flat bottom flexi pack) HDPE white rigid containersclosed with a polypropylene screw cap with an induction heat seal liner.
  • 1 L (flat bottom flexi pack) HDPE white rigid containersclosed with a polypropylene screw cap with an induction heat seal liner.
  • 5 L (jerrican) HDPE white rigid containersclosed with a polypropylene screw cap with an induction heat seal liner.
  • 2.5 L (back pack) HDPE white rigid containersclosed with a polypropylene screw cap with an induction heat seal liner.
  • 1 L (jerrican) HDPE white rigid containersclosed with a polypropylene screw cap with an induction heat seal liner.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Interchem (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Interchem (Ireland) Limited
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10555/003/002
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."